Clinical Oncology Education

The Bottleneck of Hope: Bridging the Gap in Access to Advanced Breast Cancer Therapies

• Clinical Oncology Education

The Bottleneck of Hope: Bridging the Gap in Access to Advanced Breast Cancer Therapies

Evan Lee Salim June 20, 2026

Date: Wednesday, June 23, 2026 Time: 15:00 GMT Location: Global Virtual Symposium For thousands of patients living...

Read More Read more about The Bottleneck of Hope: Bridging the Gap in Access to Advanced Breast Cancer Therapies

Precision in a Drop: How Nanowire Technology is Revolutionizing Ovarian Cancer Detection

• Clinical Oncology Education

Precision in a Drop: How Nanowire Technology is Revolutionizing Ovarian Cancer Detection

Ali Ikhwan June 18, 2026

In the landscape of modern oncology, the "holy grail" of diagnostic medicine is the ability to detect...

Read More Read more about Precision in a Drop: How Nanowire Technology is Revolutionizing Ovarian Cancer Detection

Redefining Treatment for High-Risk Biochemically Recurrent Prostate Cancer: Insights from the EMBARK Trial

• Clinical Oncology Education

Redefining Treatment for High-Risk Biochemically Recurrent Prostate Cancer: Insights from the EMBARK Trial

Rifan Muazin June 18, 2026

The landscape of prostate cancer treatment has undergone a significant transformation in recent years, particularly regarding the...

Read More Read more about Redefining Treatment for High-Risk Biochemically Recurrent Prostate Cancer: Insights from the EMBARK Trial

Frontiers in Precision Oncology: The Rise of TCR-Modified Therapies for Pancreatic Cancer

• Clinical Oncology Education

Frontiers in Precision Oncology: The Rise of TCR-Modified Therapies for Pancreatic Cancer

Raul Delapena Setiawan June 17, 2026

The landscape of oncology is currently undergoing a seismic shift. For decades, pancreatic ductal adenocarcinoma (PDAC) has...

Read More Read more about Frontiers in Precision Oncology: The Rise of TCR-Modified Therapies for Pancreatic Cancer

The Heart-Cancer Connection: Could MRI Scans Predict Future Oncology Risks?

• Clinical Oncology Education

The Heart-Cancer Connection: Could MRI Scans Predict Future Oncology Risks?

Muslim June 17, 2026

In a groundbreaking exploration of the biological interplay between cardiovascular health and oncology, a study led by...

Read More Read more about The Heart-Cancer Connection: Could MRI Scans Predict Future Oncology Risks?

Breakthrough in Blood Cancer: The QUIZOM Combination Therapy Offers New Hope for High-Risk AML Patients

• Clinical Oncology Education

Breakthrough in Blood Cancer: The QUIZOM Combination Therapy Offers New Hope for High-Risk AML Patients

Nana June 16, 2026

In a significant advancement for hematological oncology, researchers at the LKS Faculty of Medicine at the University...

Read More Read more about Breakthrough in Blood Cancer: The QUIZOM Combination Therapy Offers New Hope for High-Risk AML Patients

A Potential New Standard of Care: Landmark FrontMIND Trial Challenges Decades of Lymphoma Treatment

• Clinical Oncology Education

A Potential New Standard of Care: Landmark FrontMIND Trial Challenges Decades of Lymphoma Treatment

Nana Wu June 15, 2026

In the landscape of oncology, few standards have remained as entrenched as R-CHOP, the five-drug chemotherapy regimen...

Read More Read more about A Potential New Standard of Care: Landmark FrontMIND Trial Challenges Decades of Lymphoma Treatment

Rethinking Breast Cancer Surgery: Landmark SENOMAC Trial Challenges Standard Practice for Lymph Node Removal

• Clinical Oncology Education

Rethinking Breast Cancer Surgery: Landmark SENOMAC Trial Challenges Standard Practice for Lymph Node Removal

Muslim June 15, 2026

For decades, the standard of care for breast cancer patients whose disease had spread to the sentinel...

Read More Read more about Rethinking Breast Cancer Surgery: Landmark SENOMAC Trial Challenges Standard Practice for Lymph Node Removal

A New Dawn for Pancreatic Cancer: Daraxonrasib Nearly Doubles Survival in Landmark Phase 3 Trial

• Clinical Oncology Education

A New Dawn for Pancreatic Cancer: Daraxonrasib Nearly Doubles Survival in Landmark Phase 3 Trial

Azzam Bilal Chamdy June 15, 2026

In a development that oncology experts are calling "landscape-changing," results from the Phase 3 RASolute 302 clinical...

Read More Read more about A New Dawn for Pancreatic Cancer: Daraxonrasib Nearly Doubles Survival in Landmark Phase 3 Trial

Breakthrough in Liver Cancer Treatment: EMERALD-3 Trial Signals New Era for Unresectable Hepatocellular Carcinoma

• Clinical Oncology Education

Breakthrough in Liver Cancer Treatment: EMERALD-3 Trial Signals New Era for Unresectable Hepatocellular Carcinoma

Nana Muazin June 15, 2026

CHICAGO — A landmark clinical trial set to be presented at the 2026 American Society of Clinical...

Read More Read more about Breakthrough in Liver Cancer Treatment: EMERALD-3 Trial Signals New Era for Unresectable Hepatocellular Carcinoma